Emmaus expects roughly $400K Q3 2026 operating loss
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Emmaus Life Sciences, Inc. (EMMA) said it cannot file its Form 10-Q for the quarter ended September 30, 2026, by the prescribed due date because it needs additional time to value the conversion feature of its outstanding convertible promissory notes. It anticipates filing by the fifth calendar day following the prescribed due date.
Emmaus estimates net revenues will decline more than 40% compared with 2025, primarily following completion of its U.S. out-license of Endari to NeoImmuneTech, Inc. during Q3 2026. Gross profit is expected to decline approximately 50%. The company estimates a loss from operations of approximately $0.4 million, compared with income from operations of approximately $0.7 million in the same period in 2025, and a net loss of approximately $0.06 per share, versus $0.03 per share in 2025. The final net loss depends on the completed valuation.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- None.
Negative
- Major point. Forward-looking: it has not happened yet and may not happen.Q3 2026 net revenues expected to fall more than 40% versus 2025.
- Major point. Forward-looking: it has not happened yet and may not happen.Operating result shifts from approximately $0.7 million income to a $0.4 million loss.
Key Figures
Key Terms
conversion feature financial
convertible promissory notes financial
out-license financial
gross profit financial
loss from operations financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What Q3 2026 results does EMMA expect?
Why is EMMA's Q3 2026 10-Q late?
AI-generated analysis. How Rhea-AI works. Not financial advice.